KALVISTA PHARMACEUTICALS, INC.

Analyst Reco. KalVista Pharmaceuticals, Inc.

Equities

KALV

US4834971032

Real-time Estimate Cboe BZX Other stock markets 16:25:25 29/04/2024 BST			5-day change	1st Jan Change
11.04 ^USD	+2.37%		-4.02%	-10.37%

04-22	Kalvista Pharmaceuticals, Inc. Appoints William C. Fairey to the Board of Directors	CI
04-15	Certain Common Stock of KalVista Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 15-APR-2024.	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts Price Target on KalVista Pharmaceuticals to $24 From $16, Maintains Buy Rating	02-14	MT
SVB Securities Adjusts KalVista Pharmaceuticals' Price Target to $20 From $30, Maintains Outperform Rating	03/02/23	MT
HC Wainwright Adjusts KalVista Pharmaceuticals' Price Target to $16 From $48, Reiterates Buy Rating	06/10/22	MT
SVB Securities Adjusts Price Target on KalVista Pharmaceuticals to $30 From $45, Keeps Outperform Rating	05/10/22	MT
Needham Lowers KalVista Pharmaceuticals Price Target to $24 From $38, Maintains Buy Rating	04/10/22	MT
SVB Securities Adjusts KalVista Pharmaceuticals' Price Target to $45 from $51, Keeps Outperform Rating	08/07/22	MT
Needham Adjusts Price Target on KalVista Pharmaceuticals to $38 From $42, Reiterates Buy Rating	08/07/22	MT
Stifel Nicolaus Adjusts KalVista Pharmaceuticals' Price Target to $32 From $54, Maintains Buy Rating	08/06/22	MT
Needham Adjusts KalVista Pharmaceuticals' Price Target to $42 from $48, Keeps Buy Rating	11/03/22	MT
Cantor Fitzgerald Lowers Price Target for KalVista Pharmaceuticals to $33 From $49, Maintains Overweight Rating	10/03/22	MT
Needham Adjusts KalVista Pharmaceuticals' Price Target to $48 from $50, Keeps Buy Rating	10/12/21	MT
KALVISTA PHARMACEUTICALS : Roth Capital Adjusts Price Target on KalVista Pharmaceuticals to $55 From $30, Maintains Buy Rating	18/02/21	MT
KALVISTA PHARMACEUTICALS : SVB Leerink Adjusts Price Target on KalVista Pharmaceuticals to $51 From $39, Keeps Outperform Rating	10/02/21	MT
KALVISTA PHARMACEUTICALS : HC Wainwright Adjusts Price Target on KalVista Pharmaceuticals to $48 From $30, Maintains Buy Rating	10/02/21	MT
KALVISTA PHARMACEUTICALS : Stifel Adjusts Price Target on KalVista Pharmaceuticals to $54 From $30, Reiterates Buy Rating	09/02/21	MT
KALVISTA PHARMACEUTICALS : Needham Adjusts KalVista Pharmaceuticals' Price Target to $32 From $25, Keeps at Buy	26/01/21	MT
KALVISTA PHARMACEUTICALS : SVB Leerink Adjusts KalVista Pharmaceuticals' Price Target to $39 From $28, Keeps at Outperform	17/11/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer